1. Home
  2. ITOS vs REI Comparison

ITOS vs REI Comparison

Compare ITOS & REI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • REI
  • Stock Information
  • Founded
  • ITOS 2011
  • REI 2004
  • Country
  • ITOS United States
  • REI United States
  • Employees
  • ITOS N/A
  • REI N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • REI Oil & Gas Production
  • Sector
  • ITOS Health Care
  • REI Energy
  • Exchange
  • ITOS Nasdaq
  • REI Nasdaq
  • Market Cap
  • ITOS 270.7M
  • REI 241.9M
  • IPO Year
  • ITOS 2020
  • REI N/A
  • Fundamental
  • Price
  • ITOS $7.14
  • REI $0.92
  • Analyst Decision
  • ITOS Strong Buy
  • REI
  • Analyst Count
  • ITOS 3
  • REI 0
  • Target Price
  • ITOS $26.00
  • REI N/A
  • AVG Volume (30 Days)
  • ITOS 489.4K
  • REI 2.6M
  • Earning Date
  • ITOS 05-09-2025
  • REI 05-07-2025
  • Dividend Yield
  • ITOS N/A
  • REI N/A
  • EPS Growth
  • ITOS N/A
  • REI N/A
  • EPS
  • ITOS N/A
  • REI 0.34
  • Revenue
  • ITOS $35,000,000.00
  • REI $350,210,849.00
  • Revenue This Year
  • ITOS N/A
  • REI $11.08
  • Revenue Next Year
  • ITOS $31.74
  • REI $24.36
  • P/E Ratio
  • ITOS N/A
  • REI $2.70
  • Revenue Growth
  • ITOS 177.89
  • REI 2.13
  • 52 Week Low
  • ITOS $4.80
  • REI $0.78
  • 52 Week High
  • ITOS $18.75
  • REI $2.06
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 60.24
  • REI 45.09
  • Support Level
  • ITOS $7.01
  • REI $0.86
  • Resistance Level
  • ITOS $7.50
  • REI $0.94
  • Average True Range (ATR)
  • ITOS 0.46
  • REI 0.07
  • MACD
  • ITOS 0.23
  • REI 0.02
  • Stochastic Oscillator
  • ITOS 87.68
  • REI 67.73

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About REI Ring Energy Inc.

Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.

Share on Social Networks: